Edition:
United Kingdom

Pernix Therapeutics Holdings Inc (PTX.OQ)

PTX.OQ on NASDAQ Stock Exchange Global Market

0.75USD
18 Oct 2018
Change (% chg)

$-0.03 (-3.76%)
Prev Close
$0.77
Open
$0.77
Day's High
$0.80
Day's Low
$0.74
Volume
107,994
Avg. Vol
21,154
52-wk High
$3.30
52-wk Low
$0.74

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 21.09 -1.134
Mar '18 28.14 -1.566
FY 2017 Dec '17 41.54 -2.797
Sep '17 40.47 0.385
Jun '17 34.32 -2.158
Mar '17 29.74 -2.941
FY 2016 Dec '16 30.17 -8.908
Sep '16 41.47 -2.990
Jun '16 36.75 -4.669
Mar '16 32.47 -4.243
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.92 33.69
P/E High - Last 5 Yrs. -- 40.54 45.21
P/E Low - Last 5 Yrs. -- 23.30 23.79
Beta 1.69 0.89 0.88
Price to Sales (TTM) 0.26 3.94 5.82
Price to Book (MRQ) -- 4.77 4.89
Price to Tangible Book (MRQ) -- 5.61 6.52
Price to Cash Flow (TTM) -- 22.57 22.95
% Owned Institutions 21.30 1.13 2.14

Dividends

  Company industry sector
Dividend Yield -- 1.58 1.51
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.41 5.39
Payout Ratio(TTM) -- 46.20 43.91

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -6.61 2.20 8.02
Sales (TTM) vs TTM 1 Yr. Ago -17.36 4.64 5.75
Sales - 5 Yr. Growth Rate 18.37 9.69 9.88
EPS (MRQ) vs Qtr. 1 Yr. Ago 53.78 19.84 23.65
EPS (TTM) vs TTM 1 Yr. Ago 29.25 -- --
EPS - 5 Yr. Growth Rate -- 9.96 10.95
Capital Spending - 5 Yr. Growth Rate 41.15 15.10 14.90

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.67 2.18 2.25
Current Ratio (MRQ) 0.75 2.97 3.05
LT Debt to Equity (MRQ) -- 9.93 12.73
Total Debt to Equity (MRQ) -- 13.96 17.15
Interest Coverage (TTM) -9.29 41.56 37.58

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 70.21 55.19 54.90
Gross Margin - 5 Yr. Avg. 64.57 52.30 52.43
EBITD Margin (TTM) 4.02 -- --
EBITD - 5 Yr. Avg -0.57 18.47 11.08
Operating Margin (TTM) -93.55 14.32 4.31
Operating Margin - 5 Yr. Avg. -56.18 14.35 6.43
Pre-Tax Margin (TTM) -120.18 14.86 5.36
Pre-Tax Margin - 5 Yr. Avg. -69.72 14.80 6.86
Net Profit Margin (TTM) -120.56 11.08 1.64
Net Profit Margin - 5 Yr. Avg. -65.04 11.07 3.11
Effective Tax Rate (TTM) -- 23.36 23.24
Effective Tax Rate - 5 Yr. Avg. -- 23.60 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 733,508 911,321,905 810,573,943
Net Income/Employee (TTM) -884,286 107,240,547 95,338,757
Receivable Turnover (TTM) 2.90 5.62 5.77
Inventory Turnover (TTM) 4.45 2.61 3.62
Asset Turnover (TTM) 0.42 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -50.40 11.37 10.92
Return on Assets - 5 Yr. Avg. -23.23 12.61 12.03
Return on Investment (TTM) -74.47 14.76 14.30
Return on Investment - 5 Yr. Avg. -31.36 16.44 15.63
Return on Equity (TTM) -- 16.26 16.03
Return on Equity - 5 Yr. Avg. -138.91 17.51 16.90
  1 Year 3 Year 5 Year
Sales % -19.90 18.40 18.37
EPS (TTM) % 22.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Pernix Therapeutics Holdings Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 1.68 -1.82 50 23
13 Week -21.56 -25.38 13 33
26 Week -19.03 -25.19 25 28
52 Week -49.29 -57.02 9 12
YTD 55.67 36.71 87 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 25.43%
# of Holders: 39
Total Shares Held: 3,539,248
3 Mo. Net Change: 1,223,720
# New Positions: 2
# Closed Positions: 0
# Increased Positions: 4
# Reduced Positions: 1
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.